Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Scott Evan Eder"'
Autor:
Scott Evan Eder
Publikováno v:
LASER THERAPY. 28:103-109
Autor:
Scott Evan Eder
Publikováno v:
LASER THERAPY. 27:41-47
Background and Aim Fractional CO2 lasers have been shown to provide improvement of vulvovaginal atrophy (VVA). The aim of the current study was to assess the early effect of a fractional CO2 laser system in treating postmenopausal women with clinical
Publikováno v:
Obstetrics & Gynecology. 135:12S
Publikováno v:
Women's Health
Women use various feminine hygiene products, often as part of their daily cleansing routine; however, there is a paucity of published medical literature related to the external vulva and how personal hygiene practices can affect it. This review artic
Autor:
Scott Evan, Eder
Publikováno v:
Laser therapy. 27(1)
Fractional CO28 healthy post-menopausal women (mean age 60.1 ± 5.55 years) with VVA-related symptoms were treated with fractional COOne month following the first laser treatment, the mean VHIS score was significantly improved (13.89 ± 4.25 vs. base
Autor:
Scott Evan Eder
Publikováno v:
Women's Health. 10:499-503
Ospemifene is a novel, oral selective estrogen receptor modulator that has been approved in the USA for treatment of dyspareunia. The decline in estrogen during menopause creates vulvovaginal changes that can cause symptoms that adversely impact wome
Autor:
Scott Evan Eder
Publikováno v:
Women's Health. 10:17-27
Aim: To assess the efficacy and safety of the EmbaGYN™ Pelvic Floor Exerciser, a battery-powered neuromuscular stimulation device with a vaginal, two-electrode stimulation probe in women with stress urinary incontinence. Materials & methods: In thi
Autor:
Scott Evan Eder
Publikováno v:
Obstetrics & Gynecology. 133:146S-146S
Publikováno v:
Women's Health. 8:503-511
Aim: Excessive blood loss during menstruation is a major problem for women of reproductive age. Women who experience heavy menstrual bleeding (HMB) often present to physicians because of the subsequent negative impact HMB has on their daily lives and
Publikováno v:
Women's health (London, England). 9(4)
Aim: To evaluate the efficacy and safety of oral, modified-release tranexamic acid in women with heavy menstrual bleeding and fibroids. Materials & methods: This was a pooled analysis of two pivotal Phase III studies. Fibroids were evaluated by trans